Valeo Financial Advisors’s Endologix Inc ELGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-3,408
Closed 2114
2021
Q1
$0 Hold
3,408
﹤0.01% 2270
2020
Q4
$0 Sell
3,408
-1,382
-29% ﹤0.01% 1940
2020
Q3
$0 Hold
4,790
﹤0.01% 2303
2020
Q2
$4K Hold
4,790
﹤0.01% 1640
2020
Q1
$4K Hold
4,790
﹤0.01% 1387
2019
Q4
$8K Buy
4,790
+300
+7% +$839 ﹤0.01% 1182
2019
Q3
$18K Hold
4,490
﹤0.01% 884
2019
Q2
$33K Hold
4,490
﹤0.01% 715
2019
Q1
$30K Hold
4,490
﹤0.01% 676
2018
Q4
$32K Hold
4,490
﹤0.01% 599
2018
Q3
$55K Buy
4,490
+100
+2% +$3.57K 0.01% 531
2018
Q2
$120K Hold
4,390
0.02% 372
2018
Q1
$186K Buy
4,390
+315
+8% +$13.5K 0.03% 263
2017
Q4
$218K Buy
4,075
+415
+11% +$21.9K 0.04% 235
2017
Q3
$163K Buy
+3,660
New +$167K 0.04% 223

Valeo Financial Advisors's ELGX Position: Q2 2021 in Review

Valeo Financial Advisors sold out of Endologix Inc (ELGX) in Q2 2021, closing a stake of 3,408 shares.

Valeo Financial Advisors first reported a position in ELGX in Q3 2017 and held it in 15 quarters. The position peaked at $218K in Q4 2017. 0 funds tracked by Wall St. Rank hold ELGX as of Q2 2021.

  • Valeo Financial Advisors reported no remaining Endologix Inc position as of Q2 2021 after selling out during the quarter.
  • Valeo Financial Advisors sold 3,408 Endologix Inc shares in Q2 2021.
  • Valeo Financial Advisors first reported a position in Endologix Inc in Q3 2017 and held it in 15 quarters.
  • Valeo Financial Advisors's Endologix Inc position peaked at $218K in Q4 2017.
  • 0 funds tracked by Wall St. Rank held Endologix Inc as of Q2 2021.

Based on Valeo Financial Advisors's 13F filing for Q2 2021, filed 22 Jul 2021.